Pacira Biosciences, Inc. (PCRX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Pacira Biosciences, Inc. (PCRX)
Company Performance

Current Price

as of Oct 16, 2024

$16.63

P/E Ratio

12.93

Market Cap

$767.09M

Description

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Metrics

Overview

  • HQTampa, FL
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerPCRX
  • Price$16.63-0.36%

Trading Information

  • Market Cap$767.09M
  • Float96.67%
  • Average Daily Volume (1m)921,383
  • Average Daily Volume (3m)1,204,854
  • EPS$1.37

Company

  • Revenue$690.31M
  • Rev Growth (1yr)5.05%
  • Net Income$18.89M
  • Gross Margin67.09%
  • EBITDA Margin28.00%
  • EBITDA$49.84M
  • EV$1.69B
  • EV/Revenue2.45
  • P/E12.93
  • P/S1.22
  • P/B0.87